These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30073742)

  • 1. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery.
    Li J; Liu P
    Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent Copolymer-Based Prodrug for pH-Triggered Intracellular Release of DOX.
    Jia X; Zhao X; Tian K; Zhou T; Li J; Zhang R; Liu P
    Biomacromolecules; 2015 Nov; 16(11):3624-31. PubMed ID: 26461275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
    Pei M; Li G; Ma K; Li J; Wang Y; Liu P
    Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
    Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release.
    Li J; Li X; Liu P
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110608. PubMed ID: 31707225
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Indicating Polymer Prodrug Nanoparticles for pH-Responsive Drug Delivery in Cancer Cells and Real-Time Monitoring of Drug Release.
    Kayal S; Kola P; Pal J; Mandal M; Dhara D
    ACS Appl Bio Mater; 2024 Sep; 7(9):5810-5822. PubMed ID: 39186444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Pot Synthesis of Chicken-Feather-Keratin-Based Prodrug Nanoparticles with High Drug Content for Tumor Intracellular DOX Delivery.
    Zhang H; Liu P
    Langmuir; 2019 Jun; 35(24):8007-8014. PubMed ID: 31117737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
    Zhou T; Li J; Jia X; Zhao X; Liu P
    Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailor-Made pH-Responsive Poly(choline phosphate) Prodrug as a Drug Delivery System for Rapid Cellular Internalization.
    Wang W; Wang B; Ma X; Liu S; Shang X; Yu X
    Biomacromolecules; 2016 Jun; 17(6):2223-32. PubMed ID: 27151282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
    Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity.
    Xie P; Liu P
    Carbohydr Polym; 2022 Jan; 275():118760. PubMed ID: 34742449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.